CLINICAL_TRIALS
trial_result
· 2021-04-28
Clinical Trial Update: Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose [Phase 4]
Summary
Phase 4 trial comparing Gadovist 75% standard dose to Dotarem at full standard dose for MRI; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Magnetic Resonance Imaging | Phase 4 | Status: COMPLETED | Results posted: 2021-04-28